These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 22459739)

  • 21. Anonymous HIV surveillance with risk factor elicitation at Scotland's largest prison, Barlinnie.
    Bird AG; Gore SM; Cameron S; Ross AJ; Goldberg DJ
    AIDS; 1995 Jul; 9(7):801-8. PubMed ID: 7546427
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HIV and hepatitis C virus risk in new and longer-term injecting drug users in Oslo, Norway.
    Miller M; Mella I; Moi H; Eskild A
    J Acquir Immune Defic Syndr; 2003 Jul; 33(3):373-9. PubMed ID: 12843749
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevalence of HIV, hepatitis B and hepatitis C and associated risk behaviours amongst injecting drug users in three Afghan cities.
    Nasir A; Todd CS; Stanekzai MR; Bautista CT; Botros BA; Scott PT; Strathdee SA; Tjaden J
    Int J Drug Policy; 2011 Mar; 22(2):145-52. PubMed ID: 21146392
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hepatitis C virus infection among injecting drug users in Scotland: a review of prevalence and incidence data and the methods used to generate them.
    Roy KM; Hutchinson SJ; Wadd S; Taylor A; Cameron SO; Burns S; Molyneaux P; McIntyre PG; Goldberg DJ
    Epidemiol Infect; 2007 Apr; 135(3):433-42. PubMed ID: 16893486
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Determinants of persistent spread of HIV in HCV-infected populations of injecting drug users.
    de Vos AS; van der Helm JJ; Prins M; Kretzschmar ME
    Epidemics; 2012 Jun; 4(2):57-67. PubMed ID: 22664064
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Measuring risk of HIV and HCV among injecting drug users in the Russian Federation.
    Platt L; Sutton AJ; Vickerman P; Koshkina E; Maximova S; Latishevskaya N; Hickman M; Bonell C; Parry J; Rhodes T
    Eur J Public Health; 2009 Aug; 19(4):428-33. PubMed ID: 19349288
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Irish injecting drug users and hepatitis C: the importance of the social context of injecting.
    Smyth BP; Barry J; Keenan E
    Int J Epidemiol; 2005 Feb; 34(1):166-72. PubMed ID: 15513970
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hepatitis C incidence--a comparison between injection and noninjection drug users in New York City.
    Fuller CM; Ompad DC; Galea S; Wu Y; Koblin B; Vlahov D
    J Urban Health; 2004 Mar; 81(1):20-4. PubMed ID: 15047780
    [TBL] [Abstract][Full Text] [Related]  

  • 29. HCV infection prevalence lower than expected among 18-40-year-old injection drug users in San Diego, CA.
    Garfein RS; Rondinelli A; Barnes RF; Cuevas J; Metzner M; Velasquez M; Rodriguez D; Reilly M; Xing J; Teshale EH
    J Urban Health; 2013 Jun; 90(3):516-28. PubMed ID: 22766605
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Seroprevalence of blood-borne infections and population sizes estimates in a population of injecting drug users in Croatia.
    Kolarić B; Stajduhar D; Gajnik D; Rukavina T; Wiessing L
    Cent Eur J Public Health; 2010 Jun; 18(2):104-9. PubMed ID: 20939261
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Modelling the prevalence of HCV amongst people who inject drugs: an investigation into the risks associated with injecting paraphernalia sharing.
    Corson S; Greenhalgh D; Taylor A; Palmateer N; Goldberg D; Hutchinson S
    Drug Alcohol Depend; 2013 Nov; 133(1):172-9. PubMed ID: 23791029
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hepatitis C virus risk behaviors within the partnerships of young injecting drug users.
    Hahn JA; Evans JL; Davidson PJ; Lum PJ; Page K
    Addiction; 2010 Jul; 105(7):1254-64. PubMed ID: 20491725
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The 2004 Australian prison entrants' blood-borne virus and risk behaviour survey.
    Butler T; Boonwaat L; Hailstone S; Falconer T; Lems P; Ginley T; Read V; Smith N; Levy M; Dore G; Kaldor J
    Aust N Z J Public Health; 2007 Feb; 31(1):44-50. PubMed ID: 17333608
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Estimating the number of injecting drug users in Scotland's HCV-diagnosed population using capture-recapture methods.
    McDonald SA; Hutchinson SJ; Schnier C; McLeod A; Goldberg DJ
    Epidemiol Infect; 2014 Jan; 142(1):200-7. PubMed ID: 23522183
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Injecting behaviours and prevalence of hepatitis B, C and D markers in New Zealand injecting drug user populations.
    Kemp R; Miller J; Lungley S; Baker M
    N Z Med J; 1998 Feb; 111(1060):50-3. PubMed ID: 9539916
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hepatitis C virus infection and needle exchange use among young injection drug users in San Francisco.
    Hahn JA; Page-Shafer K; Lum PJ; Ochoa K; Moss AR
    Hepatology; 2001 Jul; 34(1):180-7. PubMed ID: 11431749
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diagnosis of hepatitis C virus infection in Scotland's injecting drug user population.
    McDonald SA; Hutchinson SJ; Mills PR; Bird SM; Robertson C; Dillon JF; Springbett A; Goldberg DJ
    Epidemiol Infect; 2010 Mar; 138(3):393-402. PubMed ID: 19723361
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Is the HCV-HIV co-infection prevalence amongst injecting drug users a marker for the level of sexual and injection related HIV transmission?
    Vickerman P; Martin NK; Roy A; Beattie T; Jarlais DD; Strathdee S; Wiessing L; Hickman M;
    Drug Alcohol Depend; 2013 Sep; 132(1-2):172-81. PubMed ID: 23453261
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The association between alcohol use and hepatitis C status among injecting drug users in Glasgow.
    O'Leary MC; Hutchinson SJ; Allen E; Palmateer N; Cameron S; Taylor A; Goldberg DJ
    Drug Alcohol Depend; 2012 Jun; 123(1-3):180-9. PubMed ID: 22137645
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Trends in hepatitis B virus, hepatitis C virus, and human immunodeficiency virus prevalence, risk behaviors, and preventive measures among Seattle injection drug users aged 18-30 years, 1994-2004.
    Burt RD; Hagan H; Garfein RS; Sabin K; Weinbaum C; Thiede H
    J Urban Health; 2007 May; 84(3):436-54. PubMed ID: 17356901
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.